Discover 1,568 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,568
A Novel Urinary Access System for Universal Transcatheter Cystoscopy at The Time of Hysterectomy
for
Hysterectomy
Location: Morristown NJ
Sponsor: Atlantic Health System
Sex: Female
Age: 18 - 70+
Code: NCT03503175
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: Paterson NJ, Hackensack NJ, New York NY, Morristown NJ,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
for
Supratentorial Hemorrhage
Location: New York NY, Edison NJ, Hershey PA, Buffalo NY,
Sponsor: Integra LifeSciences Corporation
Sex: All
Age: 18+
Code: NCT04494295
Recruiting
Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes
for
Intra-amniotic Infection
Location: NYC NY, Camden NJ, Philadelphia PA, Pittsburgh PA,
Sponsor: ProteoGenix, Inc.
Sex: Female
Age: 18+
Code: NCT00700219
Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
for
Aortoiliac Occlusive Disease
Location: New York NY, New Brunswick NJ, Camden NJ,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18 - 70+
Code: NCT06872905
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: New Haven NY, New Brunswick NJ, Voorhees Township NJ,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase1, Phase2, Recruiting
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
for
Hematologic Malignancies,
Location: Hackensack NJ, Baltimore MD, Boston MA, Chapel Hill NC,
Sponsor: Pulmotect, Inc.
Sex: All
Age: 18+
Code: NCT06665100
Phase2, Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Location: Hackensack NJ, East Brunswick NJ, Montreal, Ottawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04728893
Phase2, Recruiting
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Hackensack NJ, Lake Success NY, Charlotte NC,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06697197
Phase1, Phase2, Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for
Small Cell Lung Cancer Extensive Stage
Location: Hackensack NJ, Charlottesville VA, Edgewood KY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227597
Phase1, Phase2, Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
for
Breast Neoplasms
Location: Hackensack NJ, Jamaica NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07060807
Phase3, Recruiting
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
for
Malignant Melanoma
Location: Hackensack NJ, Fairfax VA, Toronto, Brampton,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06961006
Phase2, Recruiting
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment
for
Prostate Cancer
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: Male
Age: 18+
Code: NCT07011342
Recruiting
Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
for
Progressive Keratoconus
Location: Teaneck NJ, Westerville OH, Dothan AL
Sponsor: Glaukos Corporation
Sex: All
Age: 18 - 55
Code: NCT05314738
Phase1, Phase2, Recruiting
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
for
Advanced Solid Tumors, Malignant Neoplasm
Location: Hackensack NJ, Richmond VA, Birmingham AL, Miami FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06818643
Phase1, Phase2, Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Hackensack NJ, New Brunswick NJ, Philadelphia PA,
Sponsor: CellCentric Ltd.
Sex: All
Age: 18+
Code: NCT07096778
Phase2, Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
for
Cervical Squamous Cell Carcinoma,
Location: Hackensack NJ, New Haven CT, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT07169734
Phase1, Phase2, Recruiting
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
for
Metastatic Neoplasm
Location: Hackensack NJ, Chicago IL, Houston TX
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07030712
Phase1, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: The Bronx NY, Greenwich CT, Stamford CT, Fairfield CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)